Literature DB >> 2110031

TGF-beta 1 inhibition of transin/stromelysin gene expression is mediated through a Fos binding sequence.

L D Kerr1, D B Miller, L M Matrisian.   

Abstract

Transforming growth factor beta 1 (TGF-beta 1) inhibits the growth factor and oncogene induction of transin/stromelysin, a secreted matrix-degrading metalloprotease. We demonstrate that a 10 bp element in the transin promoter is required for the TGF-beta 1 inhibitory effects and that this sequence is conserved in the promoter regions of several other TGF-beta 1-inhibited genes. The TGF-beta 1 inhibitory element (TIE) specifically binds a nuclear protein complex from TGF-beta 1-stimulated rat fibroblasts. Interestingly, this complex contained the c-fos proto-oncogene product, Fos, and induction of Fos expression was required for the inhibitory effect of TGF-beta 1 on transin gene expression. These results suggest that TGF-beta 1 inhibition of gene expression is mediated by the binding of a Fos-containing protein complex to the TIE promoter sequences.

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2110031     DOI： 10.1016/0092-8674(90)90807-q

Source DB:  PubMed          Journal:  Cell        ISSN： 0092-8674            Impact factor:   41.582


  89 in total

1.  V-src-induced-transcription of the avian clusterin gene.

Authors:  Y Herault; G Chatelain; G Brun; D Michel
Journal:  Nucleic Acids Res       Date:  1992-12-11       Impact factor: 16.971

2.  Cloning of a growth arrest-specific and transforming growth factor beta-regulated gene, TI 1, from an epithelial cell line.

Authors:  B Kallin; R de Martin; T Etzold; V Sorrentino; L Philipson
Journal:  Mol Cell Biol       Date:  1991-10       Impact factor: 4.272

3.  Localization of stromelysin gene expression in atherosclerotic plaques by in situ hybridization.

Authors:  A M Henney; P R Wakeley; M J Davies; K Foster; R Hembry; G Murphy; S Humphries
Journal:  Proc Natl Acad Sci U S A       Date:  1991-09-15       Impact factor: 11.205

4.  Mutations in the Jun delta region suggest an inverse correlation between transformation and transcriptional activation.

Authors:  L S Håvarstein; I M Morgan; W Y Wong; P K Vogt
Journal:  Proc Natl Acad Sci U S A       Date:  1992-01-15       Impact factor: 11.205

5.  Loss of NF-kappaB control and repression of Prdx6 gene transcription by reactive oxygen species-driven SMAD3-mediated transforming growth factor beta signaling.

Authors:  Nigar Fatma; Eri Kubo; Yoshihiro Takamura; Keiichi Ishihara; Claudia Garcia; David C Beebe; Dhirendra P Singh
Journal:  J Biol Chem       Date:  2009-06-24       Impact factor: 5.157

6.  Endometrial stromal cell attachment and matrix homeostasis in abdominal wall endometriomas.

Authors:  Hiroko Itoh; Haruta Mogami; Laurice Bou Nemer; Larry Word; David Rogers; Rodney Miller; R Ann Word
Journal:  Hum Reprod       Date:  2018-02-01       Impact factor: 6.918

7.  Suppression of matrix metalloproteinase-9 transcription by transforming growth factor-beta is mediated by a nuclear factor-kappaB site.

Authors:  Kenji Ogawa; Feifei Chen; Chenzhong Kuang; Yan Chen
Journal:  Biochem J       Date:  2004-07-15       Impact factor: 3.857

8.  Heparin inhibits the induction of three matrix metalloproteinases (stromelysin, 92-kD gelatinase, and collagenase) in primate arterial smooth muscle cells.

Authors:  R D Kenagy; S T Nikkari; H G Welgus; A W Clowes
Journal:  J Clin Invest       Date:  1994-05       Impact factor: 14.808

9.  Expression of growth factors and their receptors in human esophageal carcinomas: regulation of expression by epidermal growth factor and transforming growth factor alpha.

Authors:  K Yoshida; H Kuniyasu; W Yasui; Y Kitadai; T Toge; E Tahara
Journal:  J Cancer Res Clin Oncol       Date:  1993       Impact factor: 4.553

10.  Transforming growth factor beta 1-responsive element: closely associated binding sites for USF and CCAAT-binding transcription factor-nuclear factor I in the type 1 plasminogen activator inhibitor gene.

Authors:  A Riccio; P V Pedone; L R Lund; T Olesen; H S Olsen; P A Andreasen
Journal:  Mol Cell Biol       Date:  1992-04       Impact factor: 4.272
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.